I. Related cell sub types
ID | Name | Number of studies  | |
|---|---|---|---|
| CL_0000939 | CD16-positive, CD56-dim natural killer cell, human | 21 | |
| CL_0000824 | mature natural killer cell | 0 |
ID | Name | Number of studies | |
|---|---|---|---|
| CL_0000939 | CD16-positive, CD56-dim natural killer cell, human | 21 | |
| CL_0000824 | mature natural killer cell | 0 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| KLRF1 | 17 | 62% ± 15% | 0 | 5 | |
| SH2D1B | 16 | 39% ± 13% | 0 | 4 | |
| KLRD1 | 17 | 83% ± 11% | 0 | 15 | |
| PRF1 | 17 | 84% ± 16% | 0 | 21 | |
| KLRC1 | 15 | 31% ± 15% | 0 | 8 | |
| FGFBP2 | 15 | 75% ± 13% | 0 | 11 | |
| PTGDR | 15 | 37% ± 11% | 0 | 11 | |
| GZMH | 15 | 63% ± 17% | 0 | 13 | |
| FCRL6 | 14 | 31% ± 9% | 0 | 6 | |
| ZAP70 | 16 | 51% ± 18% | 0 | 27 | |
| PYHIN1 | 15 | 46% ± 11% | 0 | 19 | |
| SH2D2A | 14 | 41% ± 12% | 0 | 20 | |
| XCL2 | 13 | 32% ± 19% | 0 | 11 | |
| NCR1 | 12 | 26% ± 7% | 0 | 3 | |
| GZMB | 17 | 82% ± 19% | 1 | 17 | |
| GNLY | 17 | 90% ± 10% | 1 | 20 | |
| GZMA | 17 | 82% ± 18% | 1 | 26 | |
| KLRB1 | 17 | 69% ± 18% | 1 | 26 | |
| FCGR3A | 16 | 66% ± 20% | 1 | 21 | |
| SAMD3 | 16 | 41% ± 14% | 1 | 22 | |
| CX3CR1 | 14 | 40% ± 18% | 1 | 11 | |
| IL2RB | 15 | 57% ± 14% | 1 | 22 | |
| NCR3 | 14 | 40% ± 10% | 1 | 12 | |
| TSPAN32 | 13 | 24% ± 6% | 1 | 8 | |
| S1PR5 | 13 | 49% ± 10% | 1 | 8 | |
| CCL3 | 15 | 34% ± 15% | 2 | 21 | |
| LCK | 16 | 46% ± 15% | 2 | 34 | |
| TXK | 17 | 42% ± 11% | 3 | 19 | |
| CD300A | 15 | 36% ± 11% | 3 | 18 | |
| CTSW | 17 | 83% ± 21% | 4 | 31 |
| GO_0002717 | Biological process | positive regulation of natural killer cell mediated immunity |
| GO_0140507 | Biological process | granzyme-mediated programmed cell death signaling pathway |
| GO_0002366 | Biological process | leukocyte activation involved in immune response |
| GO_0017038 | Biological process | protein import |
| GO_0043371 | Biological process | negative regulation of CD4-positive, alpha-beta T cell differentiation |
| GO_0030238 | Biological process | male sex determination |
| GO_0016553 | Biological process | base conversion or substitution editing |
| GO_0002418 | Biological process | immune response to tumor cell |
| GO_0030431 | Biological process | sleep |
| GO_1903479 | Biological process | mitotic actomyosin contractile ring assembly actin filament organization |
| GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
| GO_0071559 | Biological process | response to transforming growth factor beta |
| GO_0070383 | Biological process | DNA cytosine deamination |
| GO_0046085 | Biological process | adenosine metabolic process |
| GO_0042269 | Biological process | regulation of natural killer cell mediated cytotoxicity |
| GO_0032480 | Biological process | negative regulation of type I interferon production |
| GO_0010593 | Biological process | negative regulation of lamellipodium assembly |
| GO_0002296 | Biological process | T-helper 1 cell lineage commitment |
| GO_0016554 | Biological process | cytidine to uridine editing |
| GO_1902164 | Biological process | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
| GO_0048304 | Biological process | positive regulation of isotype switching to IgG isotypes |
| GO_0043378 | Biological process | positive regulation of CD8-positive, alpha-beta T cell differentiation |
| GO_0048525 | Biological process | negative regulation of viral process |
| GO_0007172 | Biological process | signal complex assembly |
| GO_0002357 | Biological process | defense response to tumor cell |
| GO_0043152 | Biological process | induction of bacterial agglutination |
| GO_1900028 | Biological process | negative regulation of ruffle assembly |
| GO_0033625 | Biological process | positive regulation of integrin activation |
| GO_0002429 | Biological process | immune response-activating cell surface receptor signaling pathway |
| GO_2000391 | Biological process | positive regulation of neutrophil extravasation |
| Cell type name | CD16-positive, CD56-dim natural killer cell, human |
| Synonyms | CD16+CD56+ NK cell CD16-positive CD56-dim NK cell CD16-positive CD56-low NK cell CD16-positive CD56-low natural killer cell CD16-positive CD56-positive NK cell CD16-positive CD56-positive natural killer cell cytotoxic CD56-dim NK cell cytotoxic CD56-dim natural killer cell |
| Description | A mature natural killer cell that has the phenotype CD56-low, CD16-positive and which is capable of cytotoxicity and cytokine production. |
| Parent | CL_0000824 |
